Lunai Bioworks
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lunai Bioworks and other ETFs, options, and stocks.About LNAI
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.
CEODavid Weinstein
CEODavid Weinstein
Employees29
Employees29
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2011
Founded2011
Employees29
Employees29
LNAI Key Statistics
Market cap25.07M
Market cap25.07M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume490.96K
Average volume490.96K
High today$1.15
High today$1.15
Low today$1.06
Low today$1.06
Open price$1.13
Open price$1.13
Volume233.58K
Volume233.58K
52 Week high$20.40
52 Week high$20.40
52 Week low$0.81
52 Week low$0.81
Stock Snapshot
With a market cap of 25.07M, Lunai Bioworks(LNAI) trades at $1.06. The stock has a price-to-earnings ratio of -0.14.
On 2025-12-14, Lunai Bioworks(LNAI) stock traded between a low of $1.06 and a high of $1.15. Shares are currently priced at $1.06, which is 0.0% above the low and -7.9% below the high.
The Lunai Bioworks(LNAI)'s current trading volume is 233.58K, compared to an average daily volume of 490.96K.
During the past year, Lunai Bioworks(LNAI) stock moved between $0.81 at its lowest and $20.40 at its peak.
During the past year, Lunai Bioworks(LNAI) stock moved between $0.81 at its lowest and $20.40 at its peak.
People also own
Based on the portfolios of people who own LNAI. This list is generated using Robinhood data, and it’s not a recommendation.